Table 5.

The prevalence of the main pulmonary manifestations.

Pulmonary Manifestations	% pSS Patients
Airway disease
Cough—Xerotrachea	41–61% [206]
Bronchiectasis	7–54% [206,210]
Interstitial lung disease	6–70% [207,210]
Non- specific interstitial pneumonia (NSIP)	29–42% * [208,209]
Usual interstitial pneumonia (UIP)	11–43% * [203,209]
Lymphocytic interstitial pneumonia (LIP)	4–15% * [111,208]
Organizing pneumonia (OP)	9.5% ** [208]
Others
MALT lymphoma	1–2% [204]

* from patients with airway disease. ** from interstitial lung disease.